Introduction
Methods
Design and Subjects
Data Collection
Anthropometric Measurements
Biochemical Measurements
Statistical Analyses
Results
Clinical characteristics | Serum irisin level among participants | p value (among the three groups) | ||
---|---|---|---|---|
Lower tertile group (n = 128) | Middle tertile group (n = 125) | Upper tertile group (n = 125) | ||
Range of serum irisin level (ng/ml) | 1.101 ~ 11.451 | 11.459 ~ 15.066 | 15.098 ~ 37.815 | |
Age (years) | 56.7 ± 8.0 | 56.5 ± 8.2 | 56.5 ± 8.6 | 0.985 |
Proportion of participants physically active according to definition (%) | 32.8% | 39.2% | 45.6% | 0.114 |
Weight (kg) | ||||
Baseline | 58.2 ± 13.1 | 58.6 ± 12.0 | 57.2 ± 13.0 | 0.652 |
Change value | 1.20 ± 3.02 | 0.60 ± 3.63 | − 0.25 ± 5.8 | 0.304 |
BMI (kg/m2) | ||||
Baseline | 23.5 ± 4.7 | 23.7 ± 4.3 | 23.5 ± 4.9 | 0.903 |
Change value | 0.22 ± 1.15 | 0.21 ± 1.37 | − 0.24 ± 1.85 | 0.020* |
WC (cm) | ||||
Baseline | 83.0 ± 11.8 | 82.1 ± 11.4 | 82.9 ± 11.9 | 0.770 |
Change value | 3.92 ± 5.52 | 4.13 ± 6.01 | 2.52 ± 6.46 | 0.071 |
FPG (mmol/L) | ||||
Baseline | 5.5 ± 0.6 | 5.7 ± 0.6 | 5.6 ± 0.7 | 0.324 |
Change value | − 0.11 ± 0.62 | − 0.21 ± 0.50 | − 0.05 ± 0.66 | 0.103 |
2hPG (mmol/L) | ||||
Baseline | 7.6 ± 2.0 | 7.4 ± 1.7 | 7.5 ± 2.2 | 0.681 |
Change value | − 0.05 ± 2.09 | 0.22 ± 1.75 | 0.38 ± 2.30 | 0.242 |
TC (mmol/L) | ||||
Baseline | 4.54 ± 1.29 | 4.53 ± 1.03 | 4.74 ± 1.22 | 0.206 |
Change value | 0.85 ± 1.47 | 0.87 ± 1.32 | 0.60 ± 1.58 | 0.268 |
TG (mmol/L)a | ||||
Baseline | 1.8 ± 1.64 | 1.49 ± 0.94 | 1.79 ± 1.66 | 0.265 |
Change value | − 0.06 ± 1.95 | 0.31 ± 1.50 | 0.10 ± 2.19 | 0.312 |
HDL-C (mmol/L) | ||||
Baseline | 1.21 ± 0.37 | 1.29 ± 0.35 | 1.32 ± 0.39 | 0.037* |
Change value | 0.25 ± 0.52 | 0.15 ± 0.48 | 0.14 ± 0.56 | 0.186 |
LDL-C (mmol/L) | ||||
Baseline | 2.55 ± 0.86 | 2.60 ± 0.76 | 2.73 ± 0.85 | 0.195 |
Change value | 0.61 ± 1.01 | 0.57 ± 1.02 | 0.35 ± 1.14 | 0.108 |
SBP (mmHg) | ||||
Baseline | 117.2 ± 16.2 | 116.8 ± 19.3 | 116.4 ± 16.3 | 0.924 |
Change value | 6.24 ± 23.50 | 2.55 ± 23.91 | 8.41 ± 27.6 | 0.373 |
DBP (mmHg) | ||||
Baseline | 75.3 ± 11.2 | 74.7 ± 10.7 | 74.7 ± 10.9 | 0.878 |
Change value | 3.58 ± 15.00 | 0.89 ± 15.04 | 2.83 ± 16.85 | 0.178 |
Body fat percentage (%) | ||||
Baseline | 32.8 ± 7.0 | 33.4 ± 7.6 | 33.2 ± 7.5 | 0.870 |
Change value | 1.01 ± 1.51 | 0.94 ± 1.64 | 0.39 ± 2.22 | 0.012* |
CVAI | ||||
Baseline | 92.9 ± 44.7 | 88.5 ± 43.9 | 91.5 ± 43.3 | 0.719 |
Change value | 10.81 ± 19.67 | 11.17 ± 19.40 | 7.01 ± 20.68 | 0.109 |
Creatinine (mmol/L) | ||||
Baseline | 68.0 ± 16.4 | 67.5 ± 14.9 | 67.6 ± 14.4 | 0.970 |
Change value | 10.18 ± 19.59 | 7.40 ± 17.57 | 9.51 ± 16.46 | 0.439 |
Clinical characteristics |
β
| P value |
---|---|---|
Age (years) | 0.002 | 0.937 |
Active physical activity score (1 = negative, 2 = positive) | 1.138 | 0.032* |
Baseline | ||
Weight (kg) | − 0.019 | 0.353 |
BMI (kg/m2) | 0.002 | 0.973 |
WC (cm) | − 0.006 | 0.778 |
Body fat percentage (%) | 0.031 | 0.375 |
CVAI | − 0.002 | 0.796 |
FPG (mmo/L) | − 0.996 | 0.023* |
2hPG (mmo/L) | − 0.123 | 0.347 |
TC (mmo/L) | 0.078 | 0.720 |
TG (mmo/L)a | − 0.187 | 0.292 |
HDL-C (mmo/L) | 0.894 | 0.199 |
LDL-C (mmo/L) | 0.312 | 0.321 |
SBP (mmHg) | − 0.002 | 0.872 |
DBP (mmHg) | − 0.007 | 0.766 |
Creatinine (mmo/L) | − 0.019 | 0.264 |
Change | ||
Weight (kg) | − 0.081 | 0.179 |
BMI (kg/m2) | − 0.533 | 0.002* |
WC (cm) | − 0.102 | 0.018* |
Body fat percentage (%) | − 0.457 | 0.001** |
CVAI | − 0.280 | 0.028* |
FPG (mmo/L) | 0.126 | 0.062 |
2hPG (mmo/L) | 0.178 | 0.058 |
TC (mmo/L) | − 0.120 | 0.680 |
TG (mmo/L)a | 0.105 | 0.770 |
LDL-C (mmo/L) | − 0.344 | 0.159 |
HDL-C (mmo/L) | − 0.297 | 0.549 |
SBP (mmHg) | − 0.005 | 0.620 |
DBP (mmHg) | − 0.004 | 0.833 |
Creatinine (mmo/L) | 0.004 | 0.803 |
Clinical characteristics | Crude OR (95% CI) | p value | Adjusted OR (95% CI)a | p value |
---|---|---|---|---|
Age | 1.735 (1.144–1.993) | 0.017* | ||
Active physical activity (negative vs. positive) | 0.758 (0.398–1.941) | 0.070 | ||
Baseline | 0.002** | |||
Serum irisin (ng/ml) | 0.952 (0.903–0.993) | 0.021* | 0.747 (0.652–0.949) | |
Weight (kg) | 0.986 (0.970–1.002) | 0.079 | ||
BMI (kg/m2) | 0.954 (0.913–0.997) | 0.034* | 0.683 (0.378–0.854) | 0.012** |
WC (cm) | 0.963 (0.734–1.783) | 0.336 | ||
Body fat percentage (%) | 0.971 (0.944–0.998) | 0.038* | ||
CVAI | 0.989 (0.726–1.998) | 0.144 | ||
FPG (mmol/L) | 0.815 (0.576–1.153) | 0.248 | ||
2hPG (mmol/L) | 0.900 (0.810–1.000) | 0.050 | ||
TC (mmol/L) | 1.146 (0.965–1.360) | 0.120 | ||
TG (mmol/L)b | 0.935 (0.809–1.080) | 0.361 | ||
HDL-C (mmol/L) | 1.220 (0.953–1.562) | 0.114 | ||
LDL-C (mmol/L) | 2.122 (1.212–3.716) | 0.008** | ||
SBP (mmHg) | 0.986 (0.974–0.998) | 0.024* | ||
DBP (mmHg) | 0.981 (0.962–0.990) | 0.042* | ||
Change | ||||
Weight (kg) | 1.145 (1.094–4.864) | 0.010** | ||
WC (cm) | 1.103 (1.099–1.553) | 0.010* | ||
Body fat percentage (%) | 1.349 (1.226–1.845) | 0.002** | 1.367 (1.233–1.513) | 0.022** |
CVAI | 1.045 (1.036–1.064) | 0.032* | ||
FPG (mmol/L) | 0.892 (0.613–1.211) | 0.892 | ||
2hPG (mmol/L) | 0.894 (0.990–1.208) | 0.894 | ||
TC (mmol/L) | 0.913 (0.866–1.142) | 0.435 | ||
TG (mmol/L)b | 0.901 (0.963–1.202) | 0.901 | ||
HDL-C (mmol/L) | 0.868 (0.391–0.998) | 0.013* | ||
LDL-C (mmol/L) | 0.893 (0.857–1.254) | 0.320 | ||
SBP (mmHg) | 0.874 (1.005–1.022) | 0.124 | ||
DBP (mmHg) | 0.867 (0.709–1.037) | 0.178 |